Cargando…

Response to Letter on “Chronic Respiratory Diseases and Neurodegenerative Disorders: A Primer for the Practicing Clinician”

Detalles Bibliográficos
Autores principales: Falsetti, Lorenzo, Viticchi, Giovanna, Zaccone, Vincenzo, Tarquinio, Nicola, Nobili, Lorenzo, Nitti, Cinzia, Salvi, Aldo, Moroncini, Gianluca, Silvestrini, Mauro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485917/
https://www.ncbi.nlm.nih.gov/pubmed/35468613
http://dx.doi.org/10.1159/000524713
_version_ 1784792165319180288
author Falsetti, Lorenzo
Viticchi, Giovanna
Zaccone, Vincenzo
Tarquinio, Nicola
Nobili, Lorenzo
Nitti, Cinzia
Salvi, Aldo
Moroncini, Gianluca
Silvestrini, Mauro
author_facet Falsetti, Lorenzo
Viticchi, Giovanna
Zaccone, Vincenzo
Tarquinio, Nicola
Nobili, Lorenzo
Nitti, Cinzia
Salvi, Aldo
Moroncini, Gianluca
Silvestrini, Mauro
author_sort Falsetti, Lorenzo
collection PubMed
description
format Online
Article
Text
id pubmed-9485917
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-94859172022-09-23 Response to Letter on “Chronic Respiratory Diseases and Neurodegenerative Disorders: A Primer for the Practicing Clinician” Falsetti, Lorenzo Viticchi, Giovanna Zaccone, Vincenzo Tarquinio, Nicola Nobili, Lorenzo Nitti, Cinzia Salvi, Aldo Moroncini, Gianluca Silvestrini, Mauro Med Princ Pract Letter to the Editor S. Karger AG 2022-04-25 /pmc/articles/PMC9485917/ /pubmed/35468613 http://dx.doi.org/10.1159/000524713 Text en Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
spellingShingle Letter to the Editor
Falsetti, Lorenzo
Viticchi, Giovanna
Zaccone, Vincenzo
Tarquinio, Nicola
Nobili, Lorenzo
Nitti, Cinzia
Salvi, Aldo
Moroncini, Gianluca
Silvestrini, Mauro
Response to Letter on “Chronic Respiratory Diseases and Neurodegenerative Disorders: A Primer for the Practicing Clinician”
title Response to Letter on “Chronic Respiratory Diseases and Neurodegenerative Disorders: A Primer for the Practicing Clinician”
title_full Response to Letter on “Chronic Respiratory Diseases and Neurodegenerative Disorders: A Primer for the Practicing Clinician”
title_fullStr Response to Letter on “Chronic Respiratory Diseases and Neurodegenerative Disorders: A Primer for the Practicing Clinician”
title_full_unstemmed Response to Letter on “Chronic Respiratory Diseases and Neurodegenerative Disorders: A Primer for the Practicing Clinician”
title_short Response to Letter on “Chronic Respiratory Diseases and Neurodegenerative Disorders: A Primer for the Practicing Clinician”
title_sort response to letter on “chronic respiratory diseases and neurodegenerative disorders: a primer for the practicing clinician”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485917/
https://www.ncbi.nlm.nih.gov/pubmed/35468613
http://dx.doi.org/10.1159/000524713
work_keys_str_mv AT falsettilorenzo responsetoletteronchronicrespiratorydiseasesandneurodegenerativedisordersaprimerforthepracticingclinician
AT viticchigiovanna responsetoletteronchronicrespiratorydiseasesandneurodegenerativedisordersaprimerforthepracticingclinician
AT zacconevincenzo responsetoletteronchronicrespiratorydiseasesandneurodegenerativedisordersaprimerforthepracticingclinician
AT tarquinionicola responsetoletteronchronicrespiratorydiseasesandneurodegenerativedisordersaprimerforthepracticingclinician
AT nobililorenzo responsetoletteronchronicrespiratorydiseasesandneurodegenerativedisordersaprimerforthepracticingclinician
AT nitticinzia responsetoletteronchronicrespiratorydiseasesandneurodegenerativedisordersaprimerforthepracticingclinician
AT salvialdo responsetoletteronchronicrespiratorydiseasesandneurodegenerativedisordersaprimerforthepracticingclinician
AT moroncinigianluca responsetoletteronchronicrespiratorydiseasesandneurodegenerativedisordersaprimerforthepracticingclinician
AT silvestrinimauro responsetoletteronchronicrespiratorydiseasesandneurodegenerativedisordersaprimerforthepracticingclinician